|
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 426.09 USD | +0.64% |
|
+0.35% | +29.08% |
| 17.07. | UNITEDHEALTH GROUP INC. : erhält Kaufen-Rating von Leerink Partners | ZM |
| 17.07. | UnitedHealth Poised for Further Growth Despite Employer Commercial Pressure, RBC Says | MT |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | % 1 Jahr | Veränd. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.64% | +0.35% | +6.27% | +31.25% | +29.08% | +50.75% | -14.78% | +1.52% | +202.73% | 387 Mrd. | |
| +0.07% | -10.36% | -3.96% | +15.50% | +6.44% | +34.65% | -15.91% | -5.20% | +176.38% | 80.92 Mrd. | |
| -0.84% | -4.09% | +0.78% | +1.01% | +2.26% | -4.82% | -1.18% | +20.37% | +111.41% | 74.45 Mrd. | |
| +3.50% | +1.98% | +10.91% | +94.99% | +56.17% | +81.48% | -9.24% | -15.06% | +150.56% | 48.02 Mrd. | |
| +3.99% | -1.35% | +8.88% | +74.06% | +61.46% | +137.71% | +0.17% | -8.56% | +84.27% | 32.81 Mrd. | |
| +0.24% | -3.40% | +15.36% | +51.29% | +29.87% | +23.17% | -25.64% | -12.35% | +329.19% | 11.74 Mrd. | |
| +2.85% | +3.88% | -5.76% | -2.92% | +4.30% | +66.00% | +275.23% | +1.63% | - | 4.26 Mrd. | |
| +0.22% | +4.18% | +22.43% | +76.21% | +24.34% | +45.14% | -21.16% | -40.47% | - | 2.5 Mrd. | |
| +5.00% | +4.05% | -7.60% | +110.96% | +96.60% | +57.14% | +335.85% | -43.66% | - | 2.43 Mrd. | |
| -0.27% | -0.38% | -2.02% | -3.35% | -22.42% | -35.09% | - | - | - | 277 Mio. | |
| Durchschnitt | +1.54% | -1.30% | +4.53% | +44.90% | +28.81% | +45.61% | +58.15% | -11.31% | +175.76% | 64.44 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | +0.80% | -1.97% | +4.92% | +33.31% | +26.87% | +48.59% | -9.16% | +0.52% | +180.93% |
- Börse
- Aktien
- 869561 Aktie
- Sektor UnitedHealth Group Inc.
Wählen Sie MarketScreener Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition
Bei der aktuellen länderspezifischen Edition bleiben